Connect with us

Technology

Navigating the Radiological Landscape: Insights into Radiotherapy and Nuclear Medicine Markets

Published

on

Advancements in AI (Artificial Intelligence) technology is poised to revolutionize radiotherapy, enhancing patient outcomes, and streamlining clinical workflows. Meanwhile, the nuclear medicine industry is witnessing rapid growth, driven by evolving therapeutic radiopharmaceuticals. These trends signal a transformative era for both fields.

BOSTON, July 22, 2024 /PRNewswire/ — According to the latest BCC Research study, the demand for “Radiotherapy, Radiopharmaceuticals and Nuclear Medicine: Global Markets” is expected to grow from $17.5 billion in 2024 and is projected to reach $31.3 billion by the end of 2029, at a compound annual growth rate (CAGR) of 12.3% during the forecast period of 2024 to 2029.”

This comprehensive report analyzes the global market for radiation therapy products (including systems, software, and services) and radiopharmaceuticals. By examining both quantitative and qualitative data, readers gain insights to assess the market, devise business strategies, and make informed decisions. BCC Research estimates market data for 2023 and forecasts values for 2024 through 2029. The report delves into radiation therapy market segmentation based on product, technology, techniques, system type, application, and region. Similarly, radiopharmaceuticals are segmented by product, application, production method, and region. Additionally, the report discusses industry growth drivers, restraints, opportunities, competitive landscapes, and emerging trends in these fields.

This report is particularly relevant now due to the significant challenges faced by the cancer care industry, such as rising costs, the necessity for personalized treatment, and a shortage of skilled healthcare staff. Healthcare professionals are increasingly seeking advanced radiotherapy devices that offer improved clinical quality and operational efficiency. There’s a growing demand for solutions that enable precise radiation delivery, efficient treatment planning, and effective data management to reduce treatment times and improve patient outcomes. Understanding these market dynamics and technological advancements is crucial for stakeholders to navigate the evolving landscape of cancer care effectively.

Please click here for more details on “The global market for radiation therapy products and radiopharmaceuticals Report.”

The following factors drive the global market for radiation therapy products and radiopharmaceuticals:

Rising Prevalence of Cancer and Chronic Conditions: The global increase in cancer and chronic diseases has heightened the demand for effective treatment options worldwide. Radiotherapy and radiopharmaceuticals have become pivotal in managing these conditions, offering crucial therapeutic avenues that complement surgery and chemotherapy.

Advances in Radiation Therapy Systems and Techniques: Innovations in radiation therapy planning and delivery systems have significantly improved treatment precision and patient outcomes. Techniques like intensity-modulated radiation therapy (IMRT) and stereotactic radiosurgery allow for highly targeted treatments, minimizing damage to surrounding healthy tissues while maximizing therapeutic effect.

Growing Demand in Developing Regions: Developing countries are experiencing rapid growth in healthcare infrastructure and awareness. As access to radiotherapy and nuclear medicine expands in these regions, there is a corresponding increase in demand for these technologies. This expansion is crucial in addressing healthcare disparities and improving treatment access for populations previously underserved.

Focus on Early Diagnosis and Screening: Early detection is critical in enhancing treatment success rates and improving patient outcomes. Nuclear medicine imaging, such as positron emission tomography (PET) scans, plays a pivotal role in the early diagnosis and staging of diseases. These technologies enable healthcare providers to detect and assess diseases at their earliest stages, facilitating timely intervention and personalized treatment strategies.

Trend Toward Precision Medicine: Precision medicine approaches are gaining prominence as healthcare shifts towards personalized treatment strategies. Radiopharmaceuticals, capable of targeting specific biological pathways and characteristics unique to individual patients, are at the forefront of this trend. They enable tailored therapies that maximize therapeutic efficacy while minimizing adverse effects, marking a significant advancement in cancer and chronic disease management.

Request a Sample Copy of The global market for radiation therapy products and radiopharmaceuticals Report.

Report Synopsis 

Report Metrics

Details

Base year considered

2023

Forecast Period considered

2024-2029

Base year market size

$16.1 billion

Market Size Forecast

$31.3 billion

Growth rate

CAGR of 12.3% for the forecast period of 2024-2029

Segment Covered

Segment, Product Type, Technology Type, Application, Production Method, and Region

Regions covered

North America, Europe, Asia-Pacific, and Rest of the World (RoW)

Key Market Drivers

 

Rising prevalence of cancer and other chronic conditions. Advances in radiation therapy planning and delivery systems and techniques. Increasing demand in developing regions. Focus on early diagnosis and screening. Trend towards precision medicine

 

Key Interesting Facts About the global market for radiation therapy products and radiopharmaceuticals:

AI Integration in Radiotherapy:

AI and machine learning advancements will lead to increased integration of these technologies into radiation therapy products and analysis software.This integration aims to enhance clinical outcomes by improving efficiency and accuracy.

Contouring and Segmentation:

AI plays a crucial role in contouring and segmenting tumors and organs at risk (OARs) within radiotherapy.Precise delineation of treatment areas is essential for effective radiation delivery.

Targeted Alpha Therapy (TAT):

TAT, also known as alpha radioimmunotherapy, is a rapidly evolving cancer treatment.It is expected to achieve a significant compound annual growth rate (CAGR) during the forecast period.

The global market for radiation therapy products and radiopharmaceuticals report includes in-depth data and analysis addressing the following important queries:

What is the projected market size and growth rate of the radiation therapy products and radiopharmaceuticals market?
•  The global radiation therapy products and radiopharmaceuticals market was estimated to be around $16.1 billion in 2023. The market is projected to reach $31.3 billion in 2029, growing at a CAGR of 12.3% during the forecast period.

What segments are covered in the market?
•  An in-depth analysis of the global radiation therapy products and radiopharmaceuticals market, including historical data and market projection on sales by technology type, product type, system type, application, and region.

By application type, which segment will dominate the market by the end of 2029?
•  By application type, the oncology segment is anticipated to dominate the market by the end of 2029.

Which product type market is growing fastest among all?
•  Therapeutic radiopharmaceuticals are the fastest growing market.

Some of the Key Market Players Are:

ACCURAY INC.CURIUMGE HEALTHCARENOVARTIS AGCARDINAL HEALTHELEKTALANTHEUSSIEMENS HEATHNIEERS AG

Directly Purchase a copy of the report with BCC Research.

For further information or to make a purchase, please get in touch with info@bccresearch.com.

About BCC Research

BCC Research provides objective, unbiased measurement and assessment of market opportunities with detailed market research reports. Our experienced industry analysts’ goal is to help you make informed business decisions, free of noise and hype.

Contact Us
Corporate HQ: 50 Milk St. Ste 16, Boston, MA 02109, USA
info@bccresearch.com,
+1 781-489-7301
For media inquiries, email press@bccresearch.com or visit our media page for access to our market research library.

Data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher.

Logo: https://mma.prnewswire.com/media/2183242/BCC_Research_Logo.jpg

 

View original content:https://www.prnewswire.com/news-releases/navigating-the-radiological-landscape-insights-into-radiotherapy-and-nuclear-medicine-markets-302202486.html

SOURCE BCC Research LLC

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

MINTO APARTMENT REIT ANNOUNCES NOVEMBER 2024 CASH DISTRIBUTION

Published

on

By

̶  Amount represents a 3% increase from previous level  ̶

OTTAWA, ON, Nov. 15, 2024 /CNW/ – Minto Apartment Real Estate Investment Trust (the “REIT”) (TSX: MI.UN) today announced a cash distribution of $0.04333 per REIT unit for the month of November 2024. Payment will be made on December 16, 2024 to unitholders of record as at November 30, 2024.

As previously announced, the amount of the November distribution represents a 3% increase from the prior level, resulting in an increase in the annualized amount of the REIT’s distribution from $0.505 per unit to $0.52 per unit.

About Minto Apartment Real Estate Investment Trust

Minto Apartment Real Estate Investment Trust is an unincorporated, open-ended real estate investment trust established pursuant to a declaration of trust under the laws of the Province of Ontario to own income-producing multi-residential properties located in urban markets in Canada. The REIT owns a portfolio of high-quality income-producing multi-residential rental properties located in Toronto, Montreal, Ottawa and Calgary. For more information on Minto Apartment REIT, please visit the REIT’s website at: https://www.mintoapartmentreit.com.

Forward-Looking Statements

This news release may contain forward-looking statements (within the meaning of applicable securities laws) relating to the business of the REIT. Forward-looking statements are identified by words such as “believe”, “anticipate”, “project”, “expect”, “intend”, “plan”, “will”, “may”, “estimate” and other similar expressions. These statements are based on the REIT’s expectations, estimates, forecasts and projections and include, without limitation, statements regarding the intended monthly distributions of the REIT. The forward-looking statements in this news release are based on certain assumptions, including without limitation that the REIT will have sufficient cash to pay its distributions. They are not guarantees of future performance and involve risks and uncertainties that are difficult to control or predict. A number of factors could cause actual results to differ materially from the results discussed in the forward-looking statements, including, but not limited to, the factors discussed and referenced under the heading “Risks and Uncertainties” in the REIT’s Q3 2024 management’s discussion and analysis dated November 12, 2024, which is available at www.sedarplus.ca. There can be no assurance that forward-looking statements will prove to be accurate as actual outcomes and results may differ materially from those expressed in these forward-looking statements. Readers, therefore, should not place undue reliance on any such forward-looking statements. Further, these forward-looking statements are made as of the date of this news release and, except as expressly required by applicable law, the REIT assumes no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events or otherwise.

SOURCE Minto Apartment Real Estate Investment Trust

Continue Reading

Technology

Equinox, Inc. Provides Notification of Cybersecurity Incident

Published

on

By

ALBANY, N.Y., Nov. 15, 2024 /PRNewswire/ — Equinox, Inc. (“Equinox”), a nonprofit provider of various counseling and health services, has learned of a cybersecurity incident that involved the personal and / or protected health information belonging to certain current and former clients, and to a number of staff. On November 15, 2024, Equinox formally notified potentially affected individuals with available address information and provided resources to assist them.

On April 29, 2024, Equinox discovered unusual activity within its digital environment. Upon discovering this activity, Equinox immediately took steps to secure its systems and enlisted independent cybersecurity forensic experts to conduct an investigation. During this time, Equinox was vigilant and able to safely minimize any disruptions to its daily operations and service delivery.

As a result of an independent forensic investigation into the incident, Equinox learned that an unauthorized actor accessed and potentially acquired certain files stored within its internal systems. Following a comprehensive review of the potentially affected data, on September 16, 2024, Equinox determined that certain employee and client information may have been subject to the unauthorized access. This information varies between individuals, but may have included names, addresses, dates of birth, Social Security numbers, passport numbers, financial account information, driver’s license and/or state identification number, medical treatment or diagnosis information, health insurance information, and/or medication-related information.

Equinox has no evidence that any of the information potentially impacted in connection with this incident has been misused. Nonetheless, Equinox has implemented additional security features to help prevent similar incidents from occurring in the future. Equinox has also reported this matter to the NYS Attorney General, NYS Division of State Police, NYS Department of State’s Division of Consumer Protection, and the Federal Office of Civil Rights.

Notification letters were mailed to impacted individuals on November 15, 2024. The letters include information about this incident and about steps that potentially impacted individuals can take to monitor and help protect their personal and protected health information. Equinox has established a toll-free call center to answer questions about the incident and to address related concerns. The call center can be reached at (866) 531-3185, Monday through Friday from 9:00 AM to 9:00 PM Eastern time.

The privacy and protection of its clients and staff and their private information is a top priority of Equinox. Equinox deeply regrets any inconvenience or concern this incident may cause.

Equinox, Inc. is a human services agency with deep roots in the Capital Region dating back to 1947. Equinox provides compassionate services and life-enhancing opportunities to youth and adults—and their families—who are impacted by domestic violence, substance use and addictions, mental health disorders, homelessness, and the challenges of living amid poverty and violence.

View original content:https://www.prnewswire.com/news-releases/equinox-inc-provides-notification-of-cybersecurity-incident-302307303.html

SOURCE Equinox, Inc.

Continue Reading

Technology

Greenberg Traurig Helps United Way Worldwide Launch Star-Studded Hurricane Relief Benefit

Published

on

By

Global law firm Greenberg Traurig, LLP provided a variety of legal support to United Way Worldwide in support of its Benefit for Hurricane Relief.

WASHINGTON, Nov. 15, 2024 /PRNewswire-PRWeb/ — Global law firm Greenberg Traurig, LLP provided a variety of legal support to United Way Worldwide in support of its Benefit for Hurricane Relief.

The one-hour special, a collaborative effort with Paramount Global that aired on CBS Television and CMT Nov. 2., brought together leading artists from across genres to mobilize communities and raise critically needed funds for relief and recovery efforts to support communities across the Southeast United States that were devastated by Hurricanes Helene and Milton.

The televised fundraising event featured performances by acclaimed artists including Brittney Spencer, Chris Janson, Clay Aiken, Jonathan McReynolds, and Tyler Hubbard. The special also included appearances by numerous entertainment industry luminaries such as the Backstreet Boys, Blake Shelton, Kelsea Ballerini, Stephen Colbert, and the Zac Brown Band, alongside community heroes Mark Starling and Tank Spencer.

The Greenberg Traurig team was led by Labor & Employment Shareholder Johnine P. Barnes in Washington, D.C., and Entertainment, Media & Sports Shareholder Paul Sarker in New York.

Learn more about the benefit event on United Way’s website.

About Greenberg Traurig: Greenberg Traurig, LLP has more than 2750 attorneys in 48 locations in the United States, Europe and the Middle East, Latin America, and Asia. The firm is a 2024 BTI “Leading Edge Law Firm” for delivering on client expectations for the future and is consistently among the top firms on the Am Law Global 100 and NLJ 500. Greenberg Traurig is Mansfield Rule Certified Plus by The Diversity Lab. The firm is recognized for powering its U.S. offices with 100% renewable energy as certified by the Center for Resource Solutions Green-e® Energy program and is a member of the U.S. EPA’s Green Power Partnership Program. The firm is known for its philanthropic giving, innovation, diversity, and pro bono. Web: http://www.gtlaw.com.

Media Contact

Jacob Fischler, Greenberg Traurig, LLP, +1 202.533.2373, fischlerj@gtlaw.com, https://www.gtlaw.com/en

Twitter

View original content:https://www.prweb.com/releases/greenberg-traurig-helps-united-way-worldwide-launch-star-studded-hurricane-relief-benefit-302307415.html

SOURCE Greenberg Traurig, LLP; Greenberg Traurig, LLP

Continue Reading

Trending